M. Schuler < M. Schulzer < M. Schwarts

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]

Ident.	Authors (with country if any)	Title
000E22 (2009)	R. Nandhagopal ; L. Kuramoto ; M. Schulzer ; E. Mak ; J. Cragg ; Chong S. Lee ; J. Mckenzie ; S. Mccormick ; A. Samii ; A. Troiano ; T J Ruth ; V. Sossi ; R. De La Fuente-Fernandez ; Donald B. Calne ; A J Stoessl	Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.
000E83 (2009)	A R Troiano [Canada] ; R. De La Fuente-Fernandez ; V. Sossi ; M. Schulzer ; E. Mak ; T J Ruth ; A J Stoessl	PET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
000F31 (2008)	R. Nandhagopal [Canada] ; E. Mak ; M. Schulzer ; J. Mckenzie ; S. Mccormick ; V. Sossi ; T J Ruth ; A. Strongosky ; M J Farrer ; Z K Wszolek ; A J Stoessl	Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study.
001452 (2003)	B C L. Lai [Canada] ; M. Schulzer ; S. Marion ; K. Teschke ; J K C. Tsui	The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
001453 (2003)	J. Carr [Canada] ; R. De La Fuente-Fernández ; M. Schulzer ; E. Mak ; S M Calne ; D B Calne	Familial and sporadic Parkinson's disease usually display the same clinical features.
001553 (2001)	P K. Pal [Canada] ; C S. Lee ; A. Samii ; M. Schulzer ; A J. Stoessl ; E K. Mak ; J. Wudel ; T. Dobko ; J K. C. Tsui	Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET
001554 (2001)	C C. Sanjiv [Canada] ; M. Schulzer ; E. Mak ; J. Fleming ; W R. W. Martin ; T. Brown ; S M. Calne ; J. Tsui ; A J. Stoessl ; C S. Lee ; D B. Calne	Daytime somnolence in patients with Parkinson's disease.
001557 (2001)	R. De La Fuente-Fernández [Canada] ; T J Ruth ; V. Sossi ; M. Schulzer ; D B Calne ; A J Stoessl	Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
001578 (2001)	R. De La Fuente-Fernández [Canada] ; J Q Lu ; V. Sossi ; S. Jivan ; M. Schulzer ; J E Holden ; C S Lee ; T J Ruth ; D B Calne ; A J Stoessl	Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
001586 (2001)	M. Schulzer [Canada]	Common pitfalls in the interpretation of statistical tests in the measurement of quality of life in Parkinson's disease.
001598 (2001)	C R Honey [Canada] ; C. Berk ; R S Palur ; M. Schulzer	Microelectrode recording for pallidotomy: mandatory, beneficial or dangerous?
001621 (2000)	P K Pal [Canada] ; A. Samii ; A. Kishore ; M. Schulzer ; E. Mak ; S. Yardley ; I M Turnbull ; D B Calne	Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years.
001632 (2000)	C S Lee [Canada] ; M A Cenci ; M. Schulzer ; A. Björklund	Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease.
001645 (2000)	C S Lee [Canada] ; A. Samii ; V. Sossi ; T J Ruth ; M. Schulzer ; J E Holden ; J. Wudel ; P K Pal ; R. De La Fuente-Fernandez ; D B Calne ; A J Stoessl	In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
001669 (2000)	R. De La Fuente-Fernández [Canada] ; P K Pal ; F J Vingerhoets ; A. Kishore ; M. Schulzer ; E K Mak ; T J Ruth ; B J Snow ; D B Calne ; A J Stoessl	Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
001681 (????)	J K Tsui ; D B Calne ; Y. Wang ; M. Schulzer ; S A Marion	Occupational risk factors in Parkinson's disease.
001697 (1999)	C R Honey [Canada] ; A J Stoessl ; J K Tsui ; M. Schulzer ; D B Calne	Unilateral pallidotomy for reduction of parkinsonian pain.
001724 (1999)	A. Samii [Canada] ; I M Turnbull ; A. Kishore ; M. Schulzer ; E. Mak ; S. Yardley ; D B Calne	Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.
001737 (????)	C. Schwab [Canada] ; M. Schulzer ; J C Steele ; P L Mcgeer	On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam.
001811 (1997)	H. Shinotoh [Canada] ; B. Thiessen ; B J Snow ; S. Hashimoto ; P. Macleod ; I. Silveira ; G A Rouleau ; M. Schulzer ; D B Calne	Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
001825 (1997)	A. Kishore [Canada] ; I M Turnbull ; B J Snow ; R. De La Fuente-Fernandez ; M. Schulzer ; E. Mak ; S. Yardley ; D B Calne	Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "M. Schulzer" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "M. Schulzer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    M. Schulzer
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022